CLAUS, Maren, FREITAG, Merle, EWALD, Meike, RODON, Lea, DEICHER, Franca, WATZL, Carsten, KOLB, Philipp Leonhard, LORENZ, Hanns-Martin, SCHMITT, Michael und MERKT, Wolfgang, 2025. Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study. Freiburg: Universität.
Elsevier - Harvard (with titles)Claus, M., Freitag, M., Ewald, M., Rodon, L., Deicher, F., Watzl, C., Kolb, P.L., Lorenz, H.-M., Schmitt, M., Merkt, W., 2025. Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study. Universität, Freiburg. https://doi.org/10.1186/s13075-024-03451-1
American Psychological Association 7th editionClaus, M., Freitag, M., Ewald, M., Rodon, L., Deicher, F., Watzl, C., Kolb, P. L., Lorenz, H.-M., Schmitt, M., & Merkt, W. (ca. 2025). Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study [Cd]. Universität. https://doi.org/10.1186/s13075-024-03451-1
Springer - Basic (author-date)Claus M, Freitag M, Ewald M, Rodon L, Deicher F, Watzl C, Kolb PL, Lorenz H-M, Schmitt M, Merkt W (2025) Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Claus, Maren/ Freitag, Merle/ Ewald, Meike/ Rodon, Lea/ Deicher, Franca/ Watzl, Carsten/ Kolb, Philipp Leonhard/ Lorenz, Hanns-Martin/ Schmitt, Michael/ Merkt, Wolfgang, Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study, Freiburg 2025.